Skip to main content

Advertisement

SpringerLink
Log in

Diabetes mellitus and colorectal carcinoma outcomes: a meta-analysis

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Objectives

The impact of diabetes mellitus (DM) on colorectal cancer (CRC) outcomes remains unknown. We studied this by conducting a meta-analysis to evaluate (1) CRC outcomes with and without DM and (2) treatment patterns.

Methods

We searched PubMed, EMBASE, Google Scholar, and CINAHL for full-text English studies from 1970 to 12/31/2017. We searched keywords, subject headings, and MESH terms to locate studies of CRC outcomes/treatment and DM. Studies were evaluated by two oncologists. Of 14,332, 48 met inclusion criteria. In accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses method, we extracted study location, design, DM definition, covariates, comparison groups, outcomes, and relative risks and/or hazard ratios. We utilized a random-effects model to pool adjusted risk estimates. Primary outcomes were all-cause mortality (ACM), disease-free survival (DFS), relapse-free survival (RFS), and cancer-specific survival (CSS). The secondary outcome was treatment patterns.

Results

Forty-eight studies were included, 42 in the meta-analysis, and 6 in the descriptive analysis, totaling > 240,000 patients. ACM was 21% worse (OR 1.21, 95% CI 1.15–1.28) and DFS was 75% worse (OR 1.75, 95% CI: 1.33–2.31) in patients with DM. No differences were detected in CSS (OR 1.10, 95% CI 0.98–1.23) or RFS (OR 1.12, 95% CI 0.91–1.38). Descriptive analysis of treatment patterns in CRC and DM suggested potentially less adjuvant therapy use in cases with DM and CRC.

Conclusions

Our meta-analysis suggests that patients with CRC and DM have worse ACM and DFS than patients without DM, suggesting that non-cancer causes of death in may account for worse outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492

    Article  PubMed  Google Scholar 

  2. International Diabetes Federation (2017) IDF Diabetes Atlas

  3. Yang Y-X, Hennessy S, Lewis JD (2005) Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol 3:587–594

    Article  PubMed  Google Scholar 

  4. Ma Y, Yang W, Song M, Smith-Warner SA, Yang J, Li Y, Ma W, Hu Y, Ogino S, Hu FB, Wen D, Chan AT, Giovannucci EL, Zhang X (2018) Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts. Br J Cancer 119:1436–1442. https://doi.org/10.1038/s41416-018-0314-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. He J, Stram DO, Kolonel LN, Henderson BE, Le Marchand L, Haiman CA (2010) The association of diabetes with colorectal cancer risk: the multiethnic cohort. Br J Cancer 103:120–126. https://doi.org/10.1038/sj.bjc.6605721

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871–1877. https://doi.org/10.1001/archinte.166.17.1871

    Article  PubMed  Google Scholar 

  7. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA (2011) Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol 106:1911–1921; quiz 1922. https://doi.org/10.1038/ajg.2011.301

    Article  PubMed  PubMed Central  Google Scholar 

  8. Koenuma M, Yamori T, Tsuruo T (1989) Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26. Jpn J Cancer Res 80:51–58

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ (1999) Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 91:620–625

    Article  CAS  PubMed  Google Scholar 

  10. Chen Y-C, Ou M-C, Fang C-W, Lee T-H, Tzeng S-L (2019) High glucose concentrations negatively regulate the IGF1R/Src/ERK axis through the microRNA-9 in colorectal mancer. Cells 8:326. https://doi.org/10.3390/cells8040326

    Article  CAS  PubMed Central  Google Scholar 

  11. Gold HT, Makarem N, Nicholson JM, Parekh N (2014) Treatment and outcomes in diabetic breast cancer patients. Breast Cancer Res Treat 143:551–570. https://doi.org/10.1007/s10549-014-2833-x

    Article  CAS  PubMed  Google Scholar 

  12. Bella F, Minicozzi P, Giacomin A, Crocetti E, Federico M, Ponz de Leon M, Fusco M, Tumino R, Mangone L, Giuliani O, Budroni M, Sant M (2013) Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients. J Cancer Res Clin Oncol 139:1303–1310. https://doi.org/10.1007/s00432-013-1439-8

    Article  PubMed  Google Scholar 

  13. Jeon JY, Jeong DH, Park MG, Lee JW, Chu SH, Park JH, Lee MK, Sato K, Ligibel JA, Meyerhardt JA, Kim NK (2013) Impact of diabetes on oncologic outcome of colorectal Cancer patients: Colon vs. Rectal Cancer. PLoS One 8:e55196. https://doi.org/10.1371/journal.pone.0055196

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Chen K-H, Shao Y-Y, Lin Z-Z, Yeh Y-C, Shau W-Y, Kuo RN, Chen HM, Lai CL, Yeh KH, Cheng AL, Lai MS (2014) Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer. Oncologist 19:951–958. https://doi.org/10.1634/theoncologist.2013-0423

    Article  PubMed  PubMed Central  Google Scholar 

  15. Luo J, Lin HC, He K, Hendryx M (2014) Diabetes and prognosis in older persons with colorectal cancer. Br J Cancer 110:1847–1854. https://doi.org/10.1038/bjc.2014.68

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Huang CW, Sun LC, Shih YL, Tsai HL, Chen CW, Yeh YS, Ma CJ, Huang CJ, Wang JY (2012) The impact on clinical outcome of high prevalence of diabetes mellitus in Taiwanese patients with colorectal cancer. World J Surg Oncol 10:76. https://doi.org/10.1186/1477-7819-10-76

    Article  PubMed  PubMed Central  Google Scholar 

  17. Karlin N, Dueck A, Cook C (2012) Cancer with diabetes: prevalence, metabolic control, and survival in an academic oncology practice. Endocr Pract 18:898–905. https://doi.org/10.4158/EP12128.OR

    Article  PubMed  Google Scholar 

  18. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269 W64

    Article  PubMed  Google Scholar 

  19. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700–b2700. https://doi.org/10.1136/bmj.b2700

    Article  PubMed  PubMed Central  Google Scholar 

  20. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP et al (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61:344–349. https://doi.org/10.1016/j.jclinepi.2007.11.008

    Article  Google Scholar 

  21. Ahmadi A, Noroozi M, Pourhoseingholi MA, Hashemi-Nazari S-S (2015) Effect of metabolic syndrome and its components on survival in colorectal cancer: a prospective study. J Ren Inj Prev 4:15–19. https://doi.org/10.12861/jrip.2015.05

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Amptoulach S, Gross G, Kalaitzakis E (2015) Differential impact of obesity and diabetes mellitus on survival after liver resection for colorectal cancer metastases. J Surg Res 199:378–385. https://doi.org/10.1016/j.jss.2015.05.059

    Article  PubMed  Google Scholar 

  23. Best LG, García-Esquinas E, Yeh J-L, Yeh F, Zhang Y, Lee ET, Howard BV, Farley JH, Welty TK, Rhoades DA, Rhoades ER, Umans JG, Navas-Acien A (2015) Association of diabetes and cancer mortality in American Indians: the Strong Heart Study. Cancer Causes Control 26:1551–1560. https://doi.org/10.1007/s10552-015-0648-7

    Article  PubMed  PubMed Central  Google Scholar 

  24. Chen CQ, Fang LK, Cai SR, Ma JP, Yang GX, Yang W et al (2010) Effects of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chin Med J. https://doi.org/10.3760/cma.j.issn.0366-6999.2010.21.024

  25. Chiao EY, Nambi PV, Naik AD (2010) The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer. J Cancer Surviv 4:381–387. https://doi.org/10.1007/s11764-010-0141-y

    Article  PubMed  PubMed Central  Google Scholar 

  26. Cossor FI, Adams-Campbell LL, Chlebowski RT, Gunter MJ, Johnson K, Martell RE, McTiernan A, Simon MS, Rohan T, Wallace RB, Paulus JK (2013) Diabetes, metformin use, and colorectal cancer survival in postmenopausal women. Cancer Epidemiol 37:742–749. https://doi.org/10.1016/j.canep.2013.04.015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167. https://doi.org/10.1093/aje/kwh161

    Article  PubMed  Google Scholar 

  28. Dehal AN, Newton CC, Jacobs EJ, Patel AV, Gapstur SM, Campbell PT (2012) Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer prevention study-II nutrition cohort. J Clin Oncol 30:53–59. https://doi.org/10.1200/JCO.2011.38.0303

    Article  PubMed  Google Scholar 

  29. Fransgaard T, Thygesen LC, Gögenur I (2016) Metformin increases overall survival in patients with diabetes undergoing surgery for colorectal cancer. Ann Surg Oncol 23:1569–1575. https://doi.org/10.1245/s10434-015-5028-8

    Article  PubMed  Google Scholar 

  30. Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME (2006) Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 54:1898–1904. https://doi.org/10.1111/j.1532-5415.2006.00973.x

    Article  PubMed  Google Scholar 

  31. Huang Y-C, Lin J-K, Chen W-S, Lin T-C, Yang S-H, Jiang J-K, Chang SC, Lan YT, Wang HS, Liu CY, Yang YW, Teng HW (2011) Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol 137:211–220. https://doi.org/10.1007/s00432-010-0879-7

    Article  PubMed  Google Scholar 

  32. Janssen-Heijnen MLG, Maas HAAM, Houterman S, Lemmens VEPP, Rutten HJT, Coebergh JWW (2007) Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer 43:2179–2193. https://doi.org/10.1016/j.ejca.2007.06.008

    Article  PubMed  Google Scholar 

  33. Jullumstrø E, Kollind M, Lydersen S, Edna TH (2009) Diabetes mellitus and outcomes of colorectal cancer. Acta Oncol (Madr) 48:361–367. https://doi.org/10.1080/02841860802637765

    Article  Google Scholar 

  34. Kaidar-Person O, Badarna H, Bar-Sela G (2015) Bevacizumab for metastatic colon cancer: does patient BMI influence survival? Anti-Cancer Drugs 26:363–366. https://doi.org/10.1097/CAD.0000000000000201

    Article  CAS  PubMed  Google Scholar 

  35. Kato I, Dyson G, Snyder M, Kim H-R, Severson RK (2016) Differential effects of patient-related factors on the outcome of radiation therapy for rectal cancer. J Radiat Oncol 5:279–286. https://doi.org/10.1007/s13566-016-0245-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Lai C-C, You J-F, Yeh C-Y, Chen J-S, Tang R, Wang J-Y, Chin CC (2011) Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Color Dis 26:473–481. https://doi.org/10.1007/s00384-010-1113-4

    Article  Google Scholar 

  37. Lee SJ, Kim JH, Park SJ, Ock SY, Kwon SK, Choi YS, Kim BK (2017) Optimal glycemic target level for colon cancer patients with diabetes. Diabetes Res Clin Pract 124:66–71. https://doi.org/10.1016/j.diabres.2016.12.009

    Article  PubMed  Google Scholar 

  38. Lemmens VEPP, Janssen-Heijnen MLG, Verheij CDGW, Houterman S, Repelaer van Driel OJ, Coebergh JWW (2005) Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 92:615–623. https://doi.org/10.1002/bjs.4913

    Article  CAS  PubMed  Google Scholar 

  39. Lieffers JR, Baracos VE, Winget M, Fassbender K (2011) A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data. Cancer 117:1957–1965. https://doi.org/10.1002/cncr.25653

    Article  PubMed  Google Scholar 

  40. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB et al (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21:433–440. https://doi.org/10.1200/JCO.2003.07.125

    Article  PubMed  Google Scholar 

  41. Morrison DS, Batty GD, Kivimaki M, Smith GD, Marmot M, Shipley M (2011) Risk factors for colonic and rectal cancer mortality: evidence from 40 years’ follow-up in the Whitehall I study. J Epidemiol Community Health 65:1053–1058. https://doi.org/10.1136/jech.2010.127555

    Article  PubMed  Google Scholar 

  42. Morrison DS, Parr CL, Lam TH, Ueshima H, Kim HC, Jee SH, Murakami Y, Giles G, Fang X, Barzi F, Batty GD, Huxley RR, Woodward M (2013) Behavioural and metabolic risk factors for mortality from colon and rectum cancer: analysis of data from the Asia-Pacific Cohort Studies Collaboration. Asian Pac J Cancer Prev 14:1083–1087

    Article  PubMed  Google Scholar 

  43. Noh GY, Hwang D-Y, Choi YH, Lee YY (2011) Effect of diabetes mellitus on outcomes of colorectal cancer. J Korean Soc Coloproctol 26:424–428. https://doi.org/10.3393/jksc.2010.26.6.424

    Article  Google Scholar 

  44. Ottaiano A, Nappi A, Tafuto S, Nasti G, De Divitiis C, Romano C et al (2016) Diabetes and body mass index are associated with neuropathy and prognosis in colon cancer patients treated with capecitabine and oxaliplatin adjuvant chemotherapy. Oncol 90:36–42. https://doi.org/10.1159/000442527

    Article  CAS  Google Scholar 

  45. Park SM, Lim MK, Shin SA, Yun YH (2006) Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 24:5017–5024. https://doi.org/10.1200/JCO.2006.07.0243

    Article  PubMed  Google Scholar 

  46. Paulus JK, Williams CD, Cossor FI, Kelley MJ, Martell RE (2016) Metformin, diabetes, and survival among U.S. veterans with colorectal cancer. Cancer Epidemiol Biomark Prev 25:1418–1425. https://doi.org/10.1158/1055-9965.EPI-16-0312

    Article  CAS  Google Scholar 

  47. Polednak AP (2006) Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev 30:466–472. https://doi.org/10.1016/j.cdp.2006.07.003

    Article  PubMed  Google Scholar 

  48. Ramjeesingh R, Orr C, Bricks CS, Hopman WM, Hammad N (2016) A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival. Curr Oncol 23:116–e122. https://doi.org/10.3747/co.23.2809

    Article  Google Scholar 

  49. Rao Kondapally Seshasai S, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841. https://doi.org/10.1056/NEJMoa1008862

    Article  PubMed  PubMed Central  Google Scholar 

  50. Sarfati D, Tan L, Blakely T, Pearce N (2011) Comorbidity among patients with colon cancer in New Zealand. N Z Med J

  51. Shan JL, Li Q, He ZX, Ren T, Zhou SF, Wang D (2015) A population-based study elicits a reverse correlation between age and overall survival in elderly patients with rectal carcinoma receiving adjuvant chemotherapy. Clin Exp Pharmacol Physiol 42:752–765. https://doi.org/10.1111/1440-1681.12420

    Article  CAS  PubMed  Google Scholar 

  52. van de Poll-Franse LV, Houterman S, Janssen-Heijnen MLG, Dercksen MW, Coebergh JWW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120:1986–1992. https://doi.org/10.1002/ijc.22532

    Article  CAS  PubMed  Google Scholar 

  53. van de Poll-Franse LV, Haak HR, Coebergh JWW, Janssen-Heijnen MLG, Lemmens VEPP (2012) Disease-specific mortality among stage I–III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia 55:2163–2172. https://doi.org/10.1007/s00125-012-2555-8

    Article  PubMed  PubMed Central  Google Scholar 

  54. Walker JJ, Brewster DH, Colhoun HM, Fischbacher CM, Lindsay RS, Wild SH (2013) Cause-specific mortality in Scottish patients with colorectal cancer with and without type 2 diabetes (2000-2007). Diabetologia 56:1531–1541. https://doi.org/10.1007/s00125-013-2917-x

    Article  CAS  PubMed  Google Scholar 

  55. Yang I-P, Tsai H-L, Huang C-W, Lu C-Y, Miao Z-F, Chang S-F et al (2016) High blood sugar levels significantly impact the prognosis of colorectal cancer patients through down-regulation of microRNA-16 by targeting <i>Myb</i> and <i>VEGFR2</i&gt. Oncotarget 7:18837–18850. https://doi.org/10.18632/oncotarget.7719

    Article  PubMed  PubMed Central  Google Scholar 

  56. Yeh H-C, Platz EA, Wang N-Y, Visvanathan K, Helzlsouer KJ, Brancati FL (2012) A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care 35:113–118. https://doi.org/10.2337/dc11-0255

    Article  PubMed  Google Scholar 

  57. Cong Z-J, Hu L-H, Xing J-J, Zhang W, Fu C-G, Yu E-D, Zhong M (2014) Risk factors associated with sphincter-preserving resection in patients with low rectal cancer. Int Surg 99:330–337. https://doi.org/10.9738/INTSURG-D-13-00217.1

    Article  PubMed  PubMed Central  Google Scholar 

  58. Sun Z, Yu X, Wang H, Ma M, Zhao Z, Wang Q (2015) Factors affecting sphincter-preserving resection treatment for patients with low rectal cancer. Exp Ther Med 10:484–490. https://doi.org/10.3892/etm.2015.2552

    Article  PubMed  PubMed Central  Google Scholar 

  59. Gross CP, McAvay GJ, Guo Z, Tinetti ME (2007) The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer 109:2410–2419. https://doi.org/10.1002/cncr.22726

    Article  PubMed  Google Scholar 

  60. Zanders MMJ, van Steenbergen LN, Haak HR, Rutten HJT, Pruijt JFM, Poortmans PMP, Lemmens VEPP, van de Poll-Franse LV (2013) Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study. Diabet Med 30:1181–1188. https://doi.org/10.1111/dme.12253

    Article  CAS  PubMed  Google Scholar 

  61. Maas HAAM, Lemmens VEPP, Cox S, Martijn H, Rutten HJT, Coebergh JWW, Janssen-Heijnen MLG (2011) The effects of age and comorbidity on treatment patterns for radiotherapy and survival in patients with mobile rectal cancer: a population-based study. Eur Geriatr Med 2:273–279. https://doi.org/10.1016/J.EURGER.2011.07.007

    Article  Google Scholar 

  62. Vissers PAJ, Mols F, Thong MSY, Pouwer F, Vreugdenhil G, van de Poll-Franse LV (2015) The impact of diabetes on neuropathic symptoms and receipt of chemotherapy among colorectal cancer patients: results from the PROFILES registry. J Cancer Surviv 9:523–531. https://doi.org/10.1007/s11764-015-0429-z

    Article  PubMed  Google Scholar 

  63. Mills KT, Bellows CF, Hoffman AE, Kelly TN, Gagliardi G (2013) Diabetes mellitus and colorectal cancer prognosis: a meta-analysis. Dis Colon Rectum 56:1304–1319. https://doi.org/10.1097/DCR.0b013e3182a479f9

    Article  PubMed  PubMed Central  Google Scholar 

  64. Zhu B, Wu X, Wu B, Pei D, Zhang L, Wei L (2017) The relationship between diabetes and colorectal cancer prognosis: a meta-analysis based on the cohort studies. PLoS One 12:1–20. https://doi.org/10.1371/journal.pone.0176068

    Article  CAS  Google Scholar 

  65. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Association of hemoglobin A 1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141:413–420. https://doi.org/10.7326/0003-4819-141-6-200409210-00006

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Grossman School of Medicine, New York University, New York, NY, 10016, USA

    Daniel J. Becker, Arjun D. Iyengar, Salman R. Punekar, Megan Griffin, Joseph Nicholson & Heather T. Gold

  2. Miller School of Medicine, University of Miami, Miami, FL, USA

    Dalia Kaakour

Authors
  1. Daniel J. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Arjun D. Iyengar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salman R. Punekar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dalia Kaakour
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Megan Griffin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joseph Nicholson
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Heather T. Gold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Salman R. Punekar.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 34 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Becker, D.J., Iyengar, A.D., Punekar, S.R. et al. Diabetes mellitus and colorectal carcinoma outcomes: a meta-analysis. Int J Colorectal Dis 35, 1989–1999 (2020). https://doi.org/10.1007/s00384-020-03666-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-020-03666-z

Keywords

Search

Navigation